SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,286 | -36.5% | 241,588 | -40.0% | 0.11% | -30.8% |
| Q2 2023 | $46,102 | -43.8% | 402,566 | -32.4% | 0.16% | -46.3% |
| Q1 2023 | $82,037 | -40.2% | 595,206 | -43.8% | 0.30% | -39.8% |
| Q4 2022 | $137,300 | -99.9% | 1,059,572 | -0.4% | 0.49% | +14.4% |
| Q3 2022 | $117,638,000 | +384.5% | 1,064,214 | +228.5% | 0.43% | +400.0% |
| Q2 2022 | $24,282,000 | -0.6% | 323,931 | +3.6% | 0.09% | +32.3% |
| Q1 2022 | $24,435,000 | -66.3% | 312,782 | -61.1% | 0.06% | -60.6% |
| Q4 2021 | $72,488,000 | +55.6% | 804,980 | +194.6% | 0.16% | +34.1% |
| Q4 2020 | $46,589,000 | +15.9% | 273,268 | -4.5% | 0.12% | -3.9% |
| Q3 2020 | $40,192,000 | -13.3% | 286,207 | -1.1% | 0.13% | -21.0% |
| Q2 2020 | $46,379,000 | +111.4% | 289,253 | +29.0% | 0.16% | +67.0% |
| Q1 2020 | $21,936,000 | -3.5% | 224,244 | +27.3% | 0.10% | +27.6% |
| Q4 2019 | $22,736,000 | +142.1% | 176,192 | +41.3% | 0.08% | +137.5% |
| Q3 2019 | $9,392,000 | -80.9% | 124,699 | -61.5% | 0.03% | -80.0% |
| Q2 2019 | $49,164,000 | +27.6% | 323,553 | +0.1% | 0.16% | +25.0% |
| Q1 2019 | $38,535,000 | +6.6% | 323,308 | -2.4% | 0.13% | -3.0% |
| Q4 2018 | $36,163,000 | -47.2% | 331,374 | -21.8% | 0.13% | -30.5% |
| Q3 2018 | $68,483,000 | -3.4% | 424,020 | -20.9% | 0.19% | -8.2% |
| Q2 2018 | $70,879,000 | +140.5% | 536,233 | +34.8% | 0.21% | +135.2% |
| Q1 2018 | $29,477,000 | -1.4% | 397,852 | -25.9% | 0.09% | +3.5% |
| Q4 2017 | $29,894,000 | +12.4% | 537,274 | -8.4% | 0.08% | +9.0% |
| Q3 2017 | $26,599,000 | +43.4% | 586,405 | +94.1% | 0.08% | +36.8% |
| Q3 2016 | $18,550,000 | -12.3% | 302,070 | -72.1% | 0.06% | -14.9% |
| Q1 2016 | $21,161,000 | -25.0% | 1,084,067 | +48.2% | 0.07% | -21.2% |
| Q4 2015 | $28,229,000 | +977.0% | 731,708 | +796.4% | 0.08% | +962.5% |
| Q3 2015 | $2,621,000 | -55.0% | 81,631 | -57.3% | 0.01% | -46.7% |
| Q2 2015 | $5,822,000 | -60.3% | 191,314 | -72.5% | 0.02% | -59.5% |
| Q3 2014 | $14,670,000 | -92.0% | 695,278 | -88.7% | 0.04% | -82.3% |
| Q2 2014 | $183,230,000 | +132.3% | 6,149,244 | +87.3% | 0.21% | +16.1% |
| Q1 2014 | $78,880,000 | +119.5% | 3,282,553 | +86.0% | 0.18% | +125.0% |
| Q4 2013 | $35,943,000 | -73.1% | 1,764,508 | -37.5% | 0.08% | -73.9% |
| Q3 2013 | $133,374,000 | +54.3% | 2,823,925 | +24.3% | 0.31% | +53.5% |
| Q2 2013 | $86,451,000 | – | 2,272,043 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |